Vivos Therapeutics (VVOS) Goodwill (2019 - 2026)

Vivos Therapeutics (VVOS) has 8 years of Goodwill data on file, last reported at $8.6 million in Q1 2026.

• On a quarterly basis, Goodwill rose 207.14% year-over-year to $8.6 million in Q1 2026; TTM through Mar 2026 was $8.6 million, a 207.14% increase from a year earlier, with the FY2025 full-year figure at $8.6 million, up 206.14% from the prior year.
• Goodwill for Q1 2026 stood at $8.6 million, roughly flat from $8.6 million in the prior quarter.
• Over the last five years, Goodwill for VVOS reached as high as $8.6 million in Q1 2026 and fell as low as $2.8 million in Q1 2023.
• Historically, Goodwill has averaged $4.2 million across 5 years, with a median of $2.8 million in 2022.
• Across the five-year window, Goodwill slipped 1.51% in 2023 and surged 207.14% in 2026, its largest moves.
• Year by year, Goodwill stood at $2.8 million in 2022, then dropped by 1.51% to $2.8 million in 2023, then changed by 0.0% to $2.8 million in 2024, then jumped by 206.14% to $8.6 million in 2025, then gained by 0.33% to $8.6 million in 2026.
• Per Business Quant data, the three most recent Goodwill figures were $8.6 million in Q1 2026, $8.6 million in Q4 2025, and $8.5 million in Q3 2025.